Baseline Characteristics of All Performed Imaging Evaluations
| Parameter | % | n |
|---|---|---|
| Localization of primary tumor | ||
| NET | 90.9 | 270 |
| Lung | 3.0 | 9 |
| Esophagus | 0.7 | 2 |
| Stomach | 4.4 | 13 |
| Pancreas | 24.9 | 75 |
| Small bowel or pancreas | 0.7 | 2 |
| Small bowel | 31.1 | 92 |
| Appendix | 1.1 | 3 |
| Colon | 4.4 | 13 |
| Rectum | 5.1 | 15 |
| Unknown primary | 7.4 | 22 |
| Not specified | 8.1 | 24 |
| Neuroendocrine carcinoma | 9.1 | 27 |
| Grading | ||
| NET | ||
| Grade 1 | 25.6 | 76 |
| Grade 2 | 50.5 | 150 |
| Grade 3 | 5.7 | 17 |
| Unknown | 9.1 | 27 |
| Neuroendocrine carcinoma | 9.1 | 27 |
| Extrahepatic metastases | ||
| Yes | 41.1 | 122 |
| No | 58.9 | 175 |
| Endocrine symptoms | ||
| Yes | 28.7 | 85 |
| Carcinoid syndrome | 5.7 | 17 |
| Diabetes | 6.4 | 19 |
| Flush | 9.7 | 29 |
| Hedinger syndrome | 1 | 3 |
| Hypertonia | 0.7 | 2 |
| Hypoglycemia | 1.3 | 4 |
| Zollinger–Ellison syndrome | 0.7 | 2 |
| Unspecified | 2.7 | 8 |
| No | 67.3 | 200 |
| Unknown | 4.0 | 12 |
| Therapy before 90Y RE | ||
| Yes | 91.6 | 272 |
| No | 8.4 | 25 |